Allergen Specific Immunotherapy in Canine Atopic Dermatitis: an Update

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Current Dermatology Reports

• Publication date

  2019-11-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s13671-019-00276-z
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Agreement of serum allergen test results with unblocked and blocked IgE against cross‐reactive carbohydrate determinants (CCD) and intradermal test results in atopic dogs

  2019cited by this paper
• Update on Allergen Immunotherapy.

  2019cited by this paper
• An open study on the efficacy of a recombinant Der f 2 (Dermatophagoides farinae) immunotherapy in atopic dogs in Hungary and Switzerland

  2018cited by this paper
• Allergen immunotherapy in people, dogs, cats and horses – differences, similarities and research needs

  2018cited by this paper
• A pilot study on the effect of oclacitinib on epicutaneous sensitization and transepidermal water loss in a colony of atopic beagle dogs

  2018cited by this paper
• Safety of specific immunotherapy using an ultra-rush induction regimen in bee and wasp allergy

  2018cited by this paper
• SUBLINGUAL IMMUNOTHERAPY FOR ALLERGIC ASTHMA AND RHINITIS.

  2018cited by this paper
• Long‐term effects of intralymphatic immunotherapy (ILIT) on canine atopic dermatitis

  2018cited by this paper
• A pilot study of immunotherapy in dogs with atopic dermatitis using a mannan‐Dermatophagoides farinae allergoid targeting dendritic cells

  2018cited by this paper
• Safety and efficacy of venom immunotherapy: a real life study

  2017cited by this paper
• A pilot study of the effect of pullulan‐conjugated Der f 2 allergen‐specific immunotherapy on canine atopic dermatitis

  2017cited by this paper
• Clinical and immunological responses of dust mite sensitive, atopic dogs to treatment with sublingual immunotherapy (SLIT).

  2016cited by this paper
• Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1.

  2016cited by this paper
• [Intralymphatic immunotherapy: An effective and safe alternative route for canine atopic dermatitis].

  2016cited by this paper
• Mechanism of action of allergen immunotherapy.

  2016cited by this paper
• Effectiveness of regionally-specific immunotherapy for the management of canine atopic dermatitis

  2016cited by this paper
• Mechanism of Action of Allergen Immunotherapy

  2016cited by this paper
• Rush sublingual immunotherapy in canine atopic dermatitis: a prospective pilot study.

  2016cited by this paper
• Allergens in veterinary medicine

  2015cited by this paper
• Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines

  2015cited by this paper
• International consensus on allergy immunotherapy.

  2015cited by this paper
• Allergen Immunotherapy: Past, Present, and Future

  2015cited by this paper
• Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens

  2015cited by this paper
• Sublingual Immunotherapy in Human and Canine Atopic Dermatitis: A Mini Review

  2014cited by this paper
• Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens.

  2014cited by this paper
• Efficacy and safety of rush immunotherapy with alumprecipitated allergens in canine atopic dermatitis

  2014cited by this paper
• Canine atopic dermatitis – what have we learned?

  2013cited by this paper
• Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development.

  2013cited by this paper
• Current understanding of the pathophysiologic mechanisms of canine atopic dermatitis.

  2012cited by this paper
• Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections.

  2012cited by this paper
• Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study.

  2012cited by this paper
• Dermatitis in a dog infected with Dirofilaria repens: clinical presentation and treatment with a spot-on solution containing 10% imidaclorpid and 2.5 moxidectin

  2011cited by this paper
• T cell responses induced by allergen‐specific immunotherapy

  2010cited by this paper
• Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase.

  2010cited by this paper
• A review of allergen-specific immunotherapy in human and veterinary medicine.

  2009cited by this paper
• Dermatophagoides farinae-specific immunotherapy in atopic dogs with hypersensitivity to multiple allergens: a randomised, double blind, placebo-controlled study.

  2009cited by this paper
• The immune privilege of the oral mucosa.

  2008cited by this paper
• Dermatophagoides farinae-specific IgG responses in atopic dogs undergoing allergen-specific immunotherapy with aqueous vaccines.

  2008cited by this paper
• Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy.

  2008cited by this paper
• Mechanisms of allergen-specific immunotherapy.

  2007cited by this paper
• Results of allergen-specific immunotherapy in 117 dogs with atopic dermatitis

  2006cited by this paper
• Revised nomenclature for veterinary allergy.

  2006cited by this paper
• Standards for practical allergen‐specific immunotherapy

  2006cited by this paper
• Intradermal testing with the storage mite Tyrophagus putrescentiae in normal dogs and dogs with atopic dermatitis in Colorado.

  2005cited by this paper
• Immunological responses to allergen immunotherapy.

  2004cited by this paper
• Allergen-specific immunotherapy induces Th1 shift in dogs with atopic dermatitis.

  2004cited by this paper
• Conventional and rush immunotherapy in canine atopic dermatitis

  2004cited by this paper
• The ACVD task force on canine atopic dermatitis (XXIV): allergen-specific immunotherapy.

  2001cited by this paper
• Evaluation of the safety of an abbreviated course of injections of allergen extracts (rush immunotherapy) for the treatment of dogs with atopic dermatitis.

  2001cited by this paper
• Allergen-specific IgE and IgGd antibodies in atopic and normal dogs.

  1998cited by this paper
• Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T‐cell clones specific for Phi p 1, a major grass pollen allergen

  1997cited by this paper
• Suppression of murine IgE responses with ovalbumin-pullulan conjugates: comparison of the suppressive effect of different conjugation methods and different molecular weights of pullulan.

  1993cited by this paper
• Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety.

  1992cited by this paper
• Effect of immunotherapy on the serum concentrations of allergen-specific IgG antibodies in dog sera.

  1989cited by this paper
• Effect of hyposensitization on atopic dermatitis in dogs.

  1984cited by this paper
• The effect of immunotherapy on humoral and cellular responses in ragweed hayfever.

  1976cited by this paper

• Malasseziose secundária a dermatite atópica canina em Shih Tzu: relato de caso

  2025cites this paper
• Management of canine atopic dermatitis. Part 1: treatment and management of flare-ups

  2025cites this paper
• Effect of Allergen-Specific Immunotherapy on Transcriptomic Changes in Canine Atopic Dermatitis

  2023cites this paper
• 2023 AAHA Management of Allergic Skin Diseases in Dogs and Cats Guidelines.

  2023cites this paper
• Cytokine and Lymphocyte Profiles in Dogs with Atopic Dermatitis after Allergen-Specific Immunotherapy

  2022cites this paper
• Challenging diagnosis and successful treatment of localised Mycobacterium avium subsp. hominissuis glossitis in a dog on long-term immunomodulatory therapy

  2022cites this paper